Evidence map›Paper›PMID 29423663›Full record

ArticlePharmaceutical research2018

Submicron Protein Particle Characterization using Resistive Pulse Sensing and Conventional Light Scattering Based Approaches.

Gregory V Barnett, Julia M Perhacs, Tapan K Das, Sambit R Kar

Abstract read
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Gregory V BarnettBiologics Characterization and Analytical Development, Bristol-Myers Squibb, Hopewell, New Jersey, USA.
Julia M PerhacsBiologics Characterization and Analytical Development, Bristol-Myers Squibb, Hopewell, New Jersey, USA.
Tapan K DasBiologics Characterization and Analytical Development, Bristol-Myers Squibb, Hopewell, New Jersey, USA.
Sambit R KarBiologics Characterization and Analytical Development, Bristol-Myers Squibb, Hopewell, New Jersey, USA. sambit.kar@bms.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeCharacterizing submicron protein particles (approximately 0.1-1μm) is challenging due to a limited number of suitable instruments capable of monitoring a relatively large continuum of particle size and concentration. In this work, we report for the first time the characterization of submicron protein particles using the high size resolution technique of resistive pulse sensing (RPS).

methodsResistive pulse sensing, dynamic light scattering and size-exclusion chromatography with in-line multi-angle light scattering (SEC-MALS) are performed on protein and placebo formulations, polystyrene size standards, placebo formulations spiked with silicone oil, and protein formulations stressed via freeze-thaw cycling, thermal incubation, and acid treatment.

resultsA method is developed for monitoring submicron protein particles using RPS. The suitable particle concentration range for RPS is found to be approximately 4 × 10

conclusionRPS is applicable for characterizing submicron particles in protein formulations with a high degree of size polydispersity. Data on submicron particle distributions provide insights into particles formation under different stresses encountered during biologics drug development.

Indexed as

Particle SizeAnimalsAntibodies, MonoclonalBiological ProductsChemistry, PharmaceuticalCHO CellsChromatography, GelCricetulusDrug DevelopmentDynamic Light ScatteringFeasibility StudiesHigh-Throughput Screening AssaysMicrofluidicsAntibodies, MonoclonalBiological Productslight scatteringprotein particleresistive pulse sensingsubmicronsubvisible

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.